René Russo
2023 - Xilio Therapeutics
In 2023, René Russo earned a total compensation of $3M as President and Chief Executive Officer at Xilio Therapeutics, a 36% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $263,120 |
|---|---|
| Option Awards | $2,124,780 |
| Salary | $598,000 |
| Other | $14,010 |
| Total | $2,999,910 |
Russo received $2.1M in option awards, accounting for 71% of the total pay in 2023.
Russo also received $263.1K in non-equity incentive plan, $598K in salary and $14K in other compensation.
Rankings
In 2023, René Russo's compensation ranked 307th out of 2,978 executives tracked by ExecPay. In other words, Russo earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 307 out of 2,978 | 90th |
Division Manufacturing | 168 out of 1,637 | 90th |
Major group Chemicals And Allied Products | 113 out of 906 | 88th |
Industry group Drugs | 110 out of 869 | 87th |
Industry Pharmaceutical Preparations | 69 out of 627 | 89th |
Source: SEC filing on April 25, 2024.
Russo's colleagues
We found three more compensation records of executives who worked with René Russo at Xilio Therapeutics in 2023.